Fragment, ModGRF, Ipamorelin (Ipamorelin) (Blend) 12 mg

HGH Fragment 176-191 6 mg, Modified GRF 3 mg, Ipamorelin 3 mg (total mixture 12 mg)

Research has shown that maximal natural release of growth hormone (GH) from the anterior pituitary gland can be achieved by combining a growth hormone-releasing hormone (GHRH) analog with a growth hormone-stimulating receptor (GHSR) agonist. 

In the case of Modified GRF, a potent GHRH analog, the effects go beyond simply increasing GH release. When Ipamorelin is added to the mixture with Modified GRF, the release of GH increases in a peak to the maximum level. Ipamorelin, known for its specificity in increasing the level of growth hormone with little additional effects, has recently been associated with the restoration of bone growth and stabilization of the matrix. These effects complement the benefits of increased GH release for bones.

Finally, with the help of Fragment 176-191, it is possible to increase targeted fat burning, which to a limited extent causes both modified GRF and Ipamorelin. Adding Fragment 176-191 to the mix — This method will speed up fat burning, especially in the conditions of increased GH release, and shift the metabolism towards the accumulation of body muscle mass.